nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—ACHE—Irinotecan—colon cancer	0.221	0.292	CbGbCtD
Procainamide—SLC22A3—Irinotecan—colon cancer	0.215	0.284	CbGbCtD
Procainamide—SLC22A3—Vincristine—colon cancer	0.188	0.248	CbGbCtD
Procainamide—BCHE—Irinotecan—colon cancer	0.133	0.176	CbGbCtD
Procainamide—Lucanthone—TOP1—colon cancer	0.00895	0.738	CrCbGaD
Procainamide—Electrocardiogram change—Fluorouracil—colon cancer	0.00552	0.0526	CcSEcCtD
Procainamide—DNMT1—Vinblastine—Vincristine—colon cancer	0.005	1	CbGdCrCtD
Procainamide—Pericarditis—Fluorouracil—colon cancer	0.00365	0.0347	CcSEcCtD
Procainamide—Gastrointestinal tract irritation—Capecitabine—colon cancer	0.00309	0.0294	CcSEcCtD
Procainamide—DNMT1—embryo—colon cancer	0.00303	0.0474	CbGeAlD
Procainamide—SCN11A—digestive system—colon cancer	0.00288	0.0451	CbGeAlD
Procainamide—DNMT1—epithelium—colon cancer	0.00247	0.0387	CbGeAlD
Procainamide—Hepatomegaly—Irinotecan—colon cancer	0.00233	0.0222	CcSEcCtD
Procainamide—SCN4A—renal system—colon cancer	0.00208	0.0327	CbGeAlD
Procainamide—SLC22A2—renal system—colon cancer	0.00191	0.03	CbGeAlD
Procainamide—DNMT1—lymphoid tissue—colon cancer	0.0019	0.0298	CbGeAlD
Procainamide—Pericarditis—Methotrexate—colon cancer	0.0019	0.0181	CcSEcCtD
Procainamide—DNMT1—digestive system—colon cancer	0.00188	0.0295	CbGeAlD
Procainamide—SCN7A—liver—colon cancer	0.00182	0.0286	CbGeAlD
Procainamide—DNMT1—bone marrow—colon cancer	0.00173	0.0272	CbGeAlD
Procainamide—SLC22A3—embryo—colon cancer	0.00171	0.0268	CbGeAlD
Procainamide—Supraventricular tachycardia—Capecitabine—colon cancer	0.00168	0.016	CcSEcCtD
Procainamide—DNMT1—vagina—colon cancer	0.00166	0.026	CbGeAlD
Procainamide—SCN3A—renal system—colon cancer	0.00162	0.0254	CbGeAlD
Procainamide—SLC22A2—digestive system—colon cancer	0.00157	0.0246	CbGeAlD
Procainamide—Hepatomegaly—Capecitabine—colon cancer	0.00156	0.0148	CcSEcCtD
Procainamide—SCN10A—lymphoid tissue—colon cancer	0.00148	0.0231	CbGeAlD
Procainamide—Pleural effusion—Capecitabine—colon cancer	0.00144	0.0137	CcSEcCtD
Procainamide—Ventricular fibrillation—Capecitabine—colon cancer	0.00144	0.0137	CcSEcCtD
Procainamide—Rash maculo-papular—Fluorouracil—colon cancer	0.00143	0.0137	CcSEcCtD
Procainamide—SLC22A4—renal system—colon cancer	0.00142	0.0222	CbGeAlD
Procainamide—DNMT1—liver—colon cancer	0.0014	0.0219	CbGeAlD
Procainamide—SCN7A—lymph node—colon cancer	0.0014	0.0219	CbGeAlD
Procainamide—Hepatic failure—Vincristine—colon cancer	0.00137	0.013	CcSEcCtD
Procainamide—SLC22A1—renal system—colon cancer	0.00135	0.0212	CbGeAlD
Procainamide—SLC22A3—smooth muscle tissue—colon cancer	0.00134	0.021	CbGeAlD
Procainamide—SCN2A—vagina—colon cancer	0.00134	0.0209	CbGeAlD
Procainamide—SCN5A—digestive system—colon cancer	0.00133	0.0208	CbGeAlD
Procainamide—SLC22A3—renal system—colon cancer	0.00129	0.0202	CbGeAlD
Procainamide—Renal impairment—Irinotecan—colon cancer	0.00126	0.012	CcSEcCtD
Procainamide—Lidocaine—EGFR—colon cancer	0.00124	0.103	CrCbGaD
Procainamide—SCN3A—bone marrow—colon cancer	0.00123	0.0192	CbGeAlD
Procainamide—SCN3A—vagina—colon cancer	0.00117	0.0184	CbGeAlD
Procainamide—Cardiac failure—Fluorouracil—colon cancer	0.00117	0.0112	CcSEcCtD
Procainamide—SCN5A—vagina—colon cancer	0.00117	0.0184	CbGeAlD
Procainamide—Lethargy—Fluorouracil—colon cancer	0.00117	0.0111	CcSEcCtD
Procainamide—Cardiac arrest—Vincristine—colon cancer	0.00117	0.0111	CcSEcCtD
Procainamide—SLC22A4—digestive system—colon cancer	0.00116	0.0182	CbGeAlD
Procainamide—Cardiac arrest—Irinotecan—colon cancer	0.00114	0.0108	CcSEcCtD
Procainamide—SCN9A—lymph node—colon cancer	0.00109	0.0172	CbGeAlD
Procainamide—Cardiac arrest—Fluorouracil—colon cancer	0.00109	0.0104	CcSEcCtD
Procainamide—DNMT1—lymph node—colon cancer	0.00107	0.0168	CbGeAlD
Procainamide—SLC22A4—bone marrow—colon cancer	0.00107	0.0168	CbGeAlD
Procainamide—Pleural effusion—Methotrexate—colon cancer	0.00107	0.0102	CcSEcCtD
Procainamide—SLC22A4—vagina—colon cancer	0.00103	0.0161	CbGeAlD
Procainamide—Neutropenia—Vincristine—colon cancer	0.000992	0.00945	CcSEcCtD
Procainamide—Eosinophilia—Fluorouracil—colon cancer	0.00098	0.00933	CcSEcCtD
Procainamide—SLC22A1—vagina—colon cancer	0.000979	0.0153	CbGeAlD
Procainamide—Neutropenia—Irinotecan—colon cancer	0.000966	0.0092	CcSEcCtD
Procainamide—BCHE—smooth muscle tissue—colon cancer	0.00095	0.0149	CbGeAlD
Procainamide—Depression—Vincristine—colon cancer	0.000943	0.00898	CcSEcCtD
Procainamide—SLC22A5—renal system—colon cancer	0.000939	0.0147	CbGeAlD
Procainamide—SLC22A3—vagina—colon cancer	0.000936	0.0147	CbGeAlD
Procainamide—Renal failure—Irinotecan—colon cancer	0.000906	0.00862	CcSEcCtD
Procainamide—Oliguria—Methotrexate—colon cancer	0.00089	0.00848	CcSEcCtD
Procainamide—Hepatic failure—Capecitabine—colon cancer	0.00089	0.00848	CcSEcCtD
Procainamide—Haemolytic anaemia—Capecitabine—colon cancer	0.000886	0.00844	CcSEcCtD
Procainamide—ACHE—lymph node—colon cancer	0.000872	0.0137	CbGeAlD
Procainamide—Hepatic enzyme increased—Methotrexate—colon cancer	0.000868	0.00826	CcSEcCtD
Procainamide—Hallucination—Vincristine—colon cancer	0.000845	0.00805	CcSEcCtD
Procainamide—Atrial fibrillation—Capecitabine—colon cancer	0.000844	0.00804	CcSEcCtD
Procainamide—Bradycardia—Irinotecan—colon cancer	0.000842	0.00802	CcSEcCtD
Procainamide—Renal impairment—Capecitabine—colon cancer	0.000841	0.00801	CcSEcCtD
Procainamide—Vasculitis—Methotrexate—colon cancer	0.000841	0.00801	CcSEcCtD
Procainamide—SCN10A—lymph node—colon cancer	0.000833	0.0131	CbGeAlD
Procainamide—SLC22A1—liver—colon cancer	0.000826	0.0129	CbGeAlD
Procainamide—Agranulocytosis—Fluorouracil—colon cancer	0.000824	0.00784	CcSEcCtD
Procainamide—Arthritis—Capecitabine—colon cancer	0.000823	0.00784	CcSEcCtD
Procainamide—Cardiac failure—Capecitabine—colon cancer	0.00082	0.00781	CcSEcCtD
Procainamide—Lethargy—Capecitabine—colon cancer	0.000817	0.00777	CcSEcCtD
Procainamide—SLC22A3—liver—colon cancer	0.000789	0.0124	CbGeAlD
Procainamide—Cardiac disorder—Vincristine—colon cancer	0.000788	0.0075	CcSEcCtD
Procainamide—SLC22A5—digestive system—colon cancer	0.00077	0.0121	CbGeAlD
Procainamide—Flushing—Irinotecan—colon cancer	0.000768	0.00731	CcSEcCtD
Procainamide—Cardiac disorder—Irinotecan—colon cancer	0.000768	0.00731	CcSEcCtD
Procainamide—Cardiac arrest—Capecitabine—colon cancer	0.000761	0.00724	CcSEcCtD
Procainamide—SCN3A—lymph node—colon cancer	0.000759	0.0119	CbGeAlD
Procainamide—BCHE—digestive system—colon cancer	0.00075	0.0118	CbGeAlD
Procainamide—Chills—Irinotecan—colon cancer	0.000742	0.00707	CcSEcCtD
Procainamide—Abdominal pain upper—Capecitabine—colon cancer	0.000731	0.00696	CcSEcCtD
Procainamide—BCHE—bone marrow—colon cancer	0.000692	0.0108	CbGeAlD
Procainamide—SLC22A5—vagina—colon cancer	0.00068	0.0107	CbGeAlD
Procainamide—Ill-defined disorder—Irinotecan—colon cancer	0.000668	0.00636	CcSEcCtD
Procainamide—SLC22A4—lymph node—colon cancer	0.000665	0.0104	CbGeAlD
Procainamide—Abdominal discomfort—Capecitabine—colon cancer	0.000663	0.00631	CcSEcCtD
Procainamide—Hepatic failure—Methotrexate—colon cancer	0.000663	0.00631	CcSEcCtD
Procainamide—BCHE—vagina—colon cancer	0.000663	0.0104	CbGeAlD
Procainamide—Malaise—Irinotecan—colon cancer	0.000649	0.00618	CcSEcCtD
Procainamide—Neutropenia—Capecitabine—colon cancer	0.000647	0.00616	CcSEcCtD
Procainamide—Convulsion—Vincristine—colon cancer	0.000641	0.0061	CcSEcCtD
Procainamide—Myalgia—Vincristine—colon cancer	0.000629	0.00599	CcSEcCtD
Procainamide—Depression—Capecitabine—colon cancer	0.000615	0.00585	CcSEcCtD
Procainamide—Lethargy—Methotrexate—colon cancer	0.000608	0.00579	CcSEcCtD
Procainamide—Renal failure—Capecitabine—colon cancer	0.000606	0.00577	CcSEcCtD
Procainamide—CYP2D6—renal system—colon cancer	0.000606	0.0095	CbGeAlD
Procainamide—Discomfort—Irinotecan—colon cancer	0.000606	0.00577	CcSEcCtD
Procainamide—SLC22A3—lymph node—colon cancer	0.000605	0.00949	CbGeAlD
Procainamide—Convulsion—Fluorouracil—colon cancer	0.000597	0.00569	CcSEcCtD
Procainamide—Confusional state—Irinotecan—colon cancer	0.000593	0.00564	CcSEcCtD
Procainamide—Thrombocytopenia—Vincristine—colon cancer	0.000591	0.00563	CcSEcCtD
Procainamide—Myalgia—Fluorouracil—colon cancer	0.000587	0.00559	CcSEcCtD
Procainamide—Discomfort—Fluorouracil—colon cancer	0.00058	0.00552	CcSEcCtD
Procainamide—Shock—Irinotecan—colon cancer	0.000578	0.0055	CcSEcCtD
Procainamide—Agranulocytosis—Capecitabine—colon cancer	0.000575	0.00548	CcSEcCtD
Procainamide—Thrombocytopenia—Irinotecan—colon cancer	0.000575	0.00548	CcSEcCtD
Procainamide—Anorexia—Vincristine—colon cancer	0.000575	0.00548	CcSEcCtD
Procainamide—SLC22A5—liver—colon cancer	0.000574	0.009	CbGeAlD
Procainamide—Confusional state—Fluorouracil—colon cancer	0.000567	0.0054	CcSEcCtD
Procainamide—Hypotension—Vincristine—colon cancer	0.000564	0.00537	CcSEcCtD
Procainamide—Bradycardia—Capecitabine—colon cancer	0.000564	0.00537	CcSEcCtD
Procainamide—Anorexia—Irinotecan—colon cancer	0.00056	0.00533	CcSEcCtD
Procainamide—BCHE—liver—colon cancer	0.000559	0.00876	CbGeAlD
Procainamide—Thrombocytopenia—Fluorouracil—colon cancer	0.000551	0.00525	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Vincristine—colon cancer	0.00055	0.00523	CcSEcCtD
Procainamide—Hypotension—Irinotecan—colon cancer	0.000549	0.00523	CcSEcCtD
Procainamide—Anorexia—Fluorouracil—colon cancer	0.000536	0.00511	CcSEcCtD
Procainamide—Hypotension—Fluorouracil—colon cancer	0.000526	0.00501	CcSEcCtD
Procainamide—Decreased appetite—Vincristine—colon cancer	0.000525	0.00499	CcSEcCtD
Procainamide—Flushing—Capecitabine—colon cancer	0.000514	0.00489	CcSEcCtD
Procainamide—Cardiac disorder—Capecitabine—colon cancer	0.000514	0.00489	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000513	0.00488	CcSEcCtD
Procainamide—Decreased appetite—Irinotecan—colon cancer	0.000511	0.00486	CcSEcCtD
Procainamide—Eosinophilia—Methotrexate—colon cancer	0.00051	0.00485	CcSEcCtD
Procainamide—CYP2D6—digestive system—colon cancer	0.000497	0.00779	CbGeAlD
Procainamide—Chills—Capecitabine—colon cancer	0.000497	0.00473	CcSEcCtD
Procainamide—Abdominal discomfort—Methotrexate—colon cancer	0.000494	0.0047	CcSEcCtD
Procainamide—Gastrointestinal pain—Vincristine—colon cancer	0.000493	0.0047	CcSEcCtD
Procainamide—Decreased appetite—Fluorouracil—colon cancer	0.000489	0.00466	CcSEcCtD
Procainamide—Feeling abnormal—Irinotecan—colon cancer	0.000484	0.00461	CcSEcCtD
Procainamide—Neutropenia—Methotrexate—colon cancer	0.000481	0.00458	CcSEcCtD
Procainamide—Gastrointestinal pain—Irinotecan—colon cancer	0.000481	0.00458	CcSEcCtD
Procainamide—Body temperature increased—Vincristine—colon cancer	0.000477	0.00454	CcSEcCtD
Procainamide—Abdominal pain—Vincristine—colon cancer	0.000477	0.00454	CcSEcCtD
Procainamide—Dysgeusia—Capecitabine—colon cancer	0.000472	0.00449	CcSEcCtD
Procainamide—Body temperature increased—Irinotecan—colon cancer	0.000465	0.00442	CcSEcCtD
Procainamide—Abdominal pain—Irinotecan—colon cancer	0.000465	0.00442	CcSEcCtD
Procainamide—Benzocaine—ABCB1—colon cancer	0.000464	0.0383	CrCbGaD
Procainamide—Feeling abnormal—Fluorouracil—colon cancer	0.000464	0.00442	CcSEcCtD
Procainamide—Depression—Methotrexate—colon cancer	0.000458	0.00436	CcSEcCtD
Procainamide—Renal failure—Methotrexate—colon cancer	0.000451	0.0043	CcSEcCtD
Procainamide—Ill-defined disorder—Capecitabine—colon cancer	0.000447	0.00426	CcSEcCtD
Procainamide—Urticaria—Fluorouracil—colon cancer	0.000447	0.00426	CcSEcCtD
Procainamide—Body temperature increased—Fluorouracil—colon cancer	0.000445	0.00424	CcSEcCtD
Procainamide—Hypersensitivity—Vincristine—colon cancer	0.000445	0.00423	CcSEcCtD
Procainamide—SLC22A5—lymph node—colon cancer	0.00044	0.0069	CbGeAlD
Procainamide—Malaise—Capecitabine—colon cancer	0.000435	0.00414	CcSEcCtD
Procainamide—Hypersensitivity—Irinotecan—colon cancer	0.000433	0.00412	CcSEcCtD
Procainamide—Asthenia—Vincristine—colon cancer	0.000433	0.00412	CcSEcCtD
Procainamide—BCHE—lymph node—colon cancer	0.000429	0.00672	CbGeAlD
Procainamide—Agranulocytosis—Methotrexate—colon cancer	0.000428	0.00408	CcSEcCtD
Procainamide—Asthenia—Irinotecan—colon cancer	0.000422	0.00401	CcSEcCtD
Procainamide—Hypersensitivity—Fluorouracil—colon cancer	0.000415	0.00395	CcSEcCtD
Procainamide—Diarrhoea—Vincristine—colon cancer	0.000413	0.00393	CcSEcCtD
Procainamide—Arthralgia—Capecitabine—colon cancer	0.00041	0.00391	CcSEcCtD
Procainamide—Myalgia—Capecitabine—colon cancer	0.00041	0.00391	CcSEcCtD
Procainamide—Discomfort—Capecitabine—colon cancer	0.000405	0.00386	CcSEcCtD
Procainamide—Diarrhoea—Irinotecan—colon cancer	0.000402	0.00383	CcSEcCtD
Procainamide—Dizziness—Vincristine—colon cancer	0.000399	0.0038	CcSEcCtD
Procainamide—Pruritus—Fluorouracil—colon cancer	0.000398	0.00379	CcSEcCtD
Procainamide—Confusional state—Capecitabine—colon cancer	0.000397	0.00378	CcSEcCtD
Procainamide—Probenecid—ABCB1—colon cancer	0.000393	0.0325	CrCbGaD
Procainamide—Dizziness—Irinotecan—colon cancer	0.000389	0.0037	CcSEcCtD
Procainamide—Aminohippurate—ABCB1—colon cancer	0.000388	0.032	CrCbGaD
Procainamide—Shock—Capecitabine—colon cancer	0.000387	0.00368	CcSEcCtD
Procainamide—Diarrhoea—Fluorouracil—colon cancer	0.000385	0.00367	CcSEcCtD
Procainamide—Thrombocytopenia—Capecitabine—colon cancer	0.000385	0.00367	CcSEcCtD
Procainamide—Vomiting—Vincristine—colon cancer	0.000384	0.00365	CcSEcCtD
Procainamide—Cardiac disorder—Methotrexate—colon cancer	0.000382	0.00364	CcSEcCtD
Procainamide—Lidocaine—ABCB1—colon cancer	0.000378	0.0312	CrCbGaD
Procainamide—Anorexia—Capecitabine—colon cancer	0.000375	0.00357	CcSEcCtD
Procainamide—Vomiting—Irinotecan—colon cancer	0.000374	0.00356	CcSEcCtD
Procainamide—Dizziness—Fluorouracil—colon cancer	0.000372	0.00354	CcSEcCtD
Procainamide—CYP2D6—liver—colon cancer	0.00037	0.00581	CbGeAlD
Procainamide—Chills—Methotrexate—colon cancer	0.00037	0.00352	CcSEcCtD
Procainamide—Hypotension—Capecitabine—colon cancer	0.000368	0.0035	CcSEcCtD
Procainamide—Nausea—Vincristine—colon cancer	0.000358	0.00341	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000358	0.00341	CcSEcCtD
Procainamide—Vomiting—Fluorouracil—colon cancer	0.000358	0.00341	CcSEcCtD
Procainamide—Dysgeusia—Methotrexate—colon cancer	0.000351	0.00334	CcSEcCtD
Procainamide—Nausea—Irinotecan—colon cancer	0.000349	0.00332	CcSEcCtD
Procainamide—Decreased appetite—Capecitabine—colon cancer	0.000342	0.00326	CcSEcCtD
Procainamide—Nausea—Fluorouracil—colon cancer	0.000334	0.00318	CcSEcCtD
Procainamide—Ill-defined disorder—Methotrexate—colon cancer	0.000333	0.00317	CcSEcCtD
Procainamide—Feeling abnormal—Capecitabine—colon cancer	0.000324	0.00309	CcSEcCtD
Procainamide—Malaise—Methotrexate—colon cancer	0.000324	0.00308	CcSEcCtD
Procainamide—Gastrointestinal pain—Capecitabine—colon cancer	0.000322	0.00306	CcSEcCtD
Procainamide—Urticaria—Capecitabine—colon cancer	0.000312	0.00297	CcSEcCtD
Procainamide—Abdominal pain—Capecitabine—colon cancer	0.000311	0.00296	CcSEcCtD
Procainamide—Body temperature increased—Capecitabine—colon cancer	0.000311	0.00296	CcSEcCtD
Procainamide—Convulsion—Methotrexate—colon cancer	0.000311	0.00296	CcSEcCtD
Procainamide—Sunitinib—ABCB1—colon cancer	0.00031	0.0255	CrCbGaD
Procainamide—Arthralgia—Methotrexate—colon cancer	0.000305	0.00291	CcSEcCtD
Procainamide—Myalgia—Methotrexate—colon cancer	0.000305	0.00291	CcSEcCtD
Procainamide—Discomfort—Methotrexate—colon cancer	0.000302	0.00287	CcSEcCtD
Procainamide—Confusional state—Methotrexate—colon cancer	0.000295	0.00281	CcSEcCtD
Procainamide—Hypersensitivity—Capecitabine—colon cancer	0.00029	0.00276	CcSEcCtD
Procainamide—Thrombocytopenia—Methotrexate—colon cancer	0.000287	0.00273	CcSEcCtD
Procainamide—Asthenia—Capecitabine—colon cancer	0.000282	0.00269	CcSEcCtD
Procainamide—Anorexia—Methotrexate—colon cancer	0.000279	0.00266	CcSEcCtD
Procainamide—Pruritus—Capecitabine—colon cancer	0.000278	0.00265	CcSEcCtD
Procainamide—Hypotension—Methotrexate—colon cancer	0.000274	0.0026	CcSEcCtD
Procainamide—Diarrhoea—Capecitabine—colon cancer	0.000269	0.00256	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000267	0.00254	CcSEcCtD
Procainamide—Dizziness—Capecitabine—colon cancer	0.00026	0.00248	CcSEcCtD
Procainamide—Decreased appetite—Methotrexate—colon cancer	0.000255	0.00242	CcSEcCtD
Procainamide—Vomiting—Capecitabine—colon cancer	0.00025	0.00238	CcSEcCtD
Procainamide—Feeling abnormal—Methotrexate—colon cancer	0.000241	0.0023	CcSEcCtD
Procainamide—Gastrointestinal pain—Methotrexate—colon cancer	0.000239	0.00228	CcSEcCtD
Procainamide—Nausea—Capecitabine—colon cancer	0.000234	0.00222	CcSEcCtD
Procainamide—Urticaria—Methotrexate—colon cancer	0.000233	0.00221	CcSEcCtD
Procainamide—Body temperature increased—Methotrexate—colon cancer	0.000231	0.0022	CcSEcCtD
Procainamide—Abdominal pain—Methotrexate—colon cancer	0.000231	0.0022	CcSEcCtD
Procainamide—Hypersensitivity—Methotrexate—colon cancer	0.000216	0.00205	CcSEcCtD
Procainamide—Asthenia—Methotrexate—colon cancer	0.00021	0.002	CcSEcCtD
Procainamide—Pruritus—Methotrexate—colon cancer	0.000207	0.00197	CcSEcCtD
Procainamide—Diarrhoea—Methotrexate—colon cancer	0.0002	0.00191	CcSEcCtD
Procainamide—Dizziness—Methotrexate—colon cancer	0.000194	0.00184	CcSEcCtD
Procainamide—Vomiting—Methotrexate—colon cancer	0.000186	0.00177	CcSEcCtD
Procainamide—Nausea—Methotrexate—colon cancer	0.000174	0.00166	CcSEcCtD
Procainamide—SCN1A—Axon guidance—SRC—colon cancer	7.72e-05	0.00134	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—NRAS—colon cancer	7.7e-05	0.00134	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—NRAS—colon cancer	7.7e-05	0.00134	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—SRC—colon cancer	7.69e-05	0.00134	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—EGFR—colon cancer	7.64e-05	0.00133	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—HRAS—colon cancer	7.58e-05	0.00132	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—VEGFA—colon cancer	7.52e-05	0.00131	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—VEGFA—colon cancer	7.52e-05	0.00131	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TGFB1—colon cancer	7.52e-05	0.00131	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—VEGFA—colon cancer	7.49e-05	0.0013	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—NRAS—colon cancer	7.43e-05	0.00129	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—NRAS—colon cancer	7.43e-05	0.00129	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CHST5—colon cancer	7.43e-05	0.00129	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ODC1—colon cancer	7.43e-05	0.00129	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—NRAS—colon cancer	7.4e-05	0.00129	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—BRAF—colon cancer	7.4e-05	0.00129	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EGFR—colon cancer	7.37e-05	0.00128	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—EGFR—colon cancer	7.31e-05	0.00127	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	7.22e-05	0.00126	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—KRAS—colon cancer	7.22e-05	0.00125	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ABCB1—colon cancer	7.17e-05	0.00125	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ABCB1—colon cancer	7.15e-05	0.00124	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—BRAF—colon cancer	7.11e-05	0.00124	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	7.03e-05	0.00122	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—EGFR—colon cancer	7.02e-05	0.00122	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—EGFR—colon cancer	7.02e-05	0.00122	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—KRAS—colon cancer	6.96e-05	0.00121	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.96e-05	0.00121	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—KRAS—colon cancer	6.9e-05	0.0012	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—BRAF—colon cancer	6.89e-05	0.0012	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CTNNB1—colon cancer	6.88e-05	0.0012	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TGFB1—colon cancer	6.87e-05	0.0012	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.8e-05	0.00118	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CA7—colon cancer	6.77e-05	0.00118	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—EGFR—colon cancer	6.77e-05	0.00118	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—EGFR—colon cancer	6.77e-05	0.00118	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EGFR—colon cancer	6.74e-05	0.00117	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—HRAS—colon cancer	6.64e-05	0.00115	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—KRAS—colon cancer	6.63e-05	0.00115	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—KRAS—colon cancer	6.63e-05	0.00115	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CTNNB1—colon cancer	6.58e-05	0.00114	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.47e-05	0.00112	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EP300—colon cancer	6.4e-05	0.00111	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—KRAS—colon cancer	6.39e-05	0.00111	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—KRAS—colon cancer	6.39e-05	0.00111	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—KRAS—colon cancer	6.37e-05	0.00111	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—BRAF—colon cancer	6.34e-05	0.0011	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CTNNB1—colon cancer	6.32e-05	0.0011	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CTNNB1—colon cancer	6.32e-05	0.0011	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.29e-05	0.00109	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—SRC—colon cancer	6.22e-05	0.00108	CbGpPWpGaD
Procainamide—ACHE—Phospholipid metabolism—PIK3CA—colon cancer	6.21e-05	0.00108	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—HRAS—colon cancer	6.13e-05	0.00107	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	6.13e-05	0.00107	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EP300—colon cancer	6.12e-05	0.00106	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CTNNB1—colon cancer	6.1e-05	0.00106	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CTNNB1—colon cancer	6.1e-05	0.00106	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—PPARG—colon cancer	6.09e-05	0.00106	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—VEGFA—colon cancer	6.06e-05	0.00105	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DLC1—colon cancer	6.04e-05	0.00105	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—NRAS—colon cancer	5.98e-05	0.00104	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—SRC—colon cancer	5.95e-05	0.00103	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—HRAS—colon cancer	5.92e-05	0.00103	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EP300—colon cancer	5.88e-05	0.00102	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EP300—colon cancer	5.88e-05	0.00102	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—HRAS—colon cancer	5.87e-05	0.00102	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—AKT1—colon cancer	5.86e-05	0.00102	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—VEGFA—colon cancer	5.79e-05	0.00101	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CASP3—colon cancer	5.77e-05	0.001	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—PPARG—colon cancer	5.75e-05	0.000999	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—NRAS—colon cancer	5.72e-05	0.000995	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—SRC—colon cancer	5.71e-05	0.000994	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—SRC—colon cancer	5.71e-05	0.000994	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LGR5—colon cancer	5.68e-05	0.000988	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EP300—colon cancer	5.67e-05	0.000985	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EP300—colon cancer	5.67e-05	0.000985	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—BRAF—colon cancer	5.67e-05	0.000985	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.64e-05	0.00098	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—HRAS—colon cancer	5.64e-05	0.00098	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—HRAS—colon cancer	5.64e-05	0.00098	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.62e-05	0.000978	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VEGFA—colon cancer	5.57e-05	0.000968	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VEGFA—colon cancer	5.57e-05	0.000968	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TGFB1—colon cancer	5.56e-05	0.000967	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—colon cancer	5.56e-05	0.000967	CbGpPWpGaD
Procainamide—BCHE—Phospholipid metabolism—PIK3CA—colon cancer	5.54e-05	0.000963	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.51e-05	0.000959	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—SRC—colon cancer	5.51e-05	0.000958	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—SRC—colon cancer	5.51e-05	0.000958	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—NRAS—colon cancer	5.5e-05	0.000956	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—NRAS—colon cancer	5.5e-05	0.000956	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EGFR—colon cancer	5.45e-05	0.000948	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—HRAS—colon cancer	5.44e-05	0.000945	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—HRAS—colon cancer	5.44e-05	0.000945	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—SRC—colon cancer	5.43e-05	0.000944	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—HRAS—colon cancer	5.41e-05	0.000941	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—colon cancer	5.37e-05	0.000933	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—colon cancer	5.37e-05	0.000933	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TGFB1—colon cancer	5.32e-05	0.000925	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—NRAS—colon cancer	5.3e-05	0.000922	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—NRAS—colon cancer	5.3e-05	0.000922	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—colon cancer	5.29e-05	0.000919	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—BRAF—colon cancer	5.28e-05	0.000918	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—AKT1—colon cancer	5.22e-05	0.000908	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—NRAS—colon cancer	5.22e-05	0.000908	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EGFR—colon cancer	5.21e-05	0.000906	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.21e-05	0.000906	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—EP300—colon cancer	5.17e-05	0.000898	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—KRAS—colon cancer	5.15e-05	0.000895	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TGFB1—colon cancer	5.11e-05	0.000888	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TGFB1—colon cancer	5.11e-05	0.000888	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—NRAS—colon cancer	5.01e-05	0.000872	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EGFR—colon cancer	5.01e-05	0.000871	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EGFR—colon cancer	5.01e-05	0.000871	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TGFB1—colon cancer	4.93e-05	0.000856	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TGFB1—colon cancer	4.93e-05	0.000856	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—KRAS—colon cancer	4.93e-05	0.000856	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—colon cancer	4.89e-05	0.000851	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EGFR—colon cancer	4.83e-05	0.00084	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EGFR—colon cancer	4.83e-05	0.00084	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.79e-05	0.000832	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—AKT1—colon cancer	4.78e-05	0.000831	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—EGFR—colon cancer	4.76e-05	0.000827	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—KRAS—colon cancer	4.73e-05	0.000823	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—KRAS—colon cancer	4.73e-05	0.000823	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.63e-05	0.000805	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—colon cancer	4.57e-05	0.000794	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—KRAS—colon cancer	4.56e-05	0.000793	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—KRAS—colon cancer	4.56e-05	0.000793	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ABCB1—colon cancer	4.5e-05	0.000782	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—KRAS—colon cancer	4.5e-05	0.000782	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—HRAS—colon cancer	4.38e-05	0.000761	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—colon cancer	4.32e-05	0.00075	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CTNNB1—colon cancer	4.29e-05	0.000745	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—HRAS—colon cancer	4.27e-05	0.000742	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ABCB1—colon cancer	4.19e-05	0.000729	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—HRAS—colon cancer	4.19e-05	0.000728	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.13e-05	0.000718	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ODC1—colon cancer	4.1e-05	0.000713	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CHST5—colon cancer	4.1e-05	0.000713	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AXIN2—colon cancer	4.08e-05	0.00071	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—HRAS—colon cancer	4.02e-05	0.000699	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—HRAS—colon cancer	4.02e-05	0.000699	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EP300—colon cancer	3.98e-05	0.000693	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—colon cancer	3.97e-05	0.000689	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.91e-05	0.00068	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—HRAS—colon cancer	3.88e-05	0.000674	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—HRAS—colon cancer	3.88e-05	0.000674	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—SRC—colon cancer	3.87e-05	0.000674	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—AKT1—colon cancer	3.86e-05	0.000672	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—HRAS—colon cancer	3.82e-05	0.000664	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—HRAS—colon cancer	3.81e-05	0.000662	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—colon cancer	3.77e-05	0.000656	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—NRAS—colon cancer	3.73e-05	0.000648	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—AKT1—colon cancer	3.7e-05	0.000643	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.68e-05	0.00064	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—AKT1—colon cancer	3.55e-05	0.000617	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—AKT1—colon cancer	3.55e-05	0.000617	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—colon cancer	3.46e-05	0.000602	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—AKT1—colon cancer	3.42e-05	0.000595	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—AKT1—colon cancer	3.42e-05	0.000595	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	3.4e-05	0.000591	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EGFR—colon cancer	3.4e-05	0.00059	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ABCB1—colon cancer	3.36e-05	0.000584	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TYMS—colon cancer	3.3e-05	0.000573	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MYC—colon cancer	3.28e-05	0.00057	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—HRAS—colon cancer	3.27e-05	0.000568	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.25e-05	0.000565	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—KRAS—colon cancer	3.21e-05	0.000558	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—HRAS—colon cancer	3.17e-05	0.000551	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—HRAS—colon cancer	2.92e-05	0.000507	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.9e-05	0.000504	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—HRAS—colon cancer	2.73e-05	0.000474	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.7e-05	0.00047	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCB1—colon cancer	2.64e-05	0.00046	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—HRAS—colon cancer	2.61e-05	0.000453	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TYMS—colon cancer	2.6e-05	0.000451	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CTNNB1—colon cancer	2.51e-05	0.000437	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—HRAS—colon cancer	2.43e-05	0.000422	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.41e-05	0.000419	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—colon cancer	2.41e-05	0.000419	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCB1—colon cancer	2.36e-05	0.00041	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—colon cancer	2.34e-05	0.000406	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TYMS—colon cancer	2.32e-05	0.000403	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—colon cancer	2.27e-05	0.000395	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CTNNB1—colon cancer	2.24e-05	0.00039	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCB1—colon cancer	2.11e-05	0.000366	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TYMS—colon cancer	2.07e-05	0.00036	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2e-05	0.000347	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCB1—colon cancer	1.96e-05	0.000341	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TYMS—colon cancer	1.93e-05	0.000335	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—colon cancer	1.84e-05	0.00032	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—colon cancer	1.84e-05	0.000319	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.78e-05	0.00031	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—colon cancer	1.64e-05	0.000285	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—EP300—colon cancer	1.53e-05	0.000266	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—colon cancer	1.47e-05	0.000255	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—colon cancer	1.45e-05	0.000251	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—colon cancer	1.37e-05	0.000237	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—colon cancer	1.29e-05	0.000224	CbGpPWpGaD
Procainamide—ACHE—Metabolism—EP300—colon cancer	1.2e-05	0.000209	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGFR3—colon cancer	1.18e-05	0.000205	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—colon cancer	1.15e-05	0.0002	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CA—colon cancer	1.13e-05	0.000197	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCB1—colon cancer	1.08e-05	0.000188	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APC—colon cancer	1.08e-05	0.000188	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—NRAS—colon cancer	1.08e-05	0.000188	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—colon cancer	1.07e-05	0.000187	CbGpPWpGaD
Procainamide—BCHE—Metabolism—EP300—colon cancer	1.07e-05	0.000187	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TYMS—colon cancer	1.06e-05	0.000185	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BRAF—colon cancer	1.02e-05	0.000177	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—colon cancer	9.86e-06	0.000171	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—EP300—colon cancer	9.59e-06	0.000167	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CA—colon cancer	9.42e-06	0.000164	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—KRAS—colon cancer	9.31e-06	0.000162	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—colon cancer	9.24e-06	0.000161	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—EP300—colon cancer	8.93e-06	0.000155	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CA—colon cancer	8.9e-06	0.000155	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CA—colon cancer	8.56e-06	0.000149	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CA—colon cancer	7.94e-06	0.000138	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HRAS—colon cancer	7.92e-06	0.000138	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—colon cancer	7.7e-06	0.000134	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASP3—colon cancer	7.63e-06	0.000133	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—colon cancer	7.54e-06	0.000131	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCND1—colon cancer	7.42e-06	0.000129	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CTNNB1—colon cancer	7.35e-06	0.000128	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—colon cancer	7.27e-06	0.000126	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1A—colon cancer	7.18e-06	0.000125	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CA—colon cancer	7.09e-06	0.000123	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—colon cancer	6.99e-06	0.000122	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EP300—colon cancer	6.83e-06	0.000119	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SRC—colon cancer	6.65e-06	0.000116	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CA—colon cancer	6.61e-06	0.000115	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—colon cancer	6.49e-06	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—colon cancer	6.47e-06	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NRAS—colon cancer	6.39e-06	0.000111	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—colon cancer	5.96e-06	0.000104	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—colon cancer	5.94e-06	0.000103	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—colon cancer	5.93e-06	0.000103	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—colon cancer	5.82e-06	0.000101	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—colon cancer	5.79e-06	0.000101	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KRAS—colon cancer	5.5e-06	9.57e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—colon cancer	5.4e-06	9.39e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CA—colon cancer	5.06e-06	8.79e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—EP300—colon cancer	4.93e-06	8.58e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—colon cancer	4.89e-06	8.5e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HRAS—colon cancer	4.68e-06	8.13e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—colon cancer	4.13e-06	7.18e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CA—colon cancer	3.65e-06	6.35e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—colon cancer	2.98e-06	5.18e-05	CbGpPWpGaD
